Literature DB >> 18077033

Simultaneous tumour dose escalation and liver sparing in Stereotactic Body Radiation Therapy (SBRT) for liver tumours due to CTV-to-PTV margin reduction.

Silvia Molinelli1, Jacco de Pooter, Alejandra Méndez Romero, Wouter Wunderink, Mauro Cattaneo, Riccardo Calandrino, Ben Heijmen.   

Abstract

PURPOSE: To quantify potential benefits of CTV-to-PTV margin reduction for SBRT of liver tumours, as allowed by enhanced treatment precision.
MATERIALS AND METHODS: For 14 patients plans were generated for the clinical margin and for 3 tighter margins. An in-house developed algorithm was used to optimise beam directions, shapes, and weights for generation of the plan with the highest isocenter dose (D(iso)), while keeping the minimum PTV dose at least 65%xD(iso) and strictly adhering to all imposed hard OAR constraints. Each plan contains 10 optimal beam directions, automatically selected from up to 252 coplanar and non-coplanar input directions.
RESULTS: Apart from the expected tumour dose escalation (D(iso), EUD(PTV), gEUD(PTV)) with decreasing margin, a simultaneous improved sparing of the normal liver (D33%, D50%, D(mean)) was also observed. The smaller the margin was, the bigger both effects were. For renormalized plans with D(iso) equal to the clinical value (3x19.2Gy), and a margin reduction of 50% (2.5mm laterally, 5mm longitudinally), normal liver D33% and D50% reduced on average by 22% (maximum 38%), and 26% (maximum 47%), respectively.
CONCLUSIONS: Using an algorithm for beam direction, shape and weight optimisation, large increases in the therapeutic ratio of liver plans could be obtained for reduced margins.

Entities:  

Mesh:

Year:  2008        PMID: 18077033     DOI: 10.1016/j.radonc.2007.11.015

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Motion-compensated estimation of delivered dose during external beam radiation therapy: implementation in Philips' Pinnacle(3) treatment planning system.

Authors:  Shyam Bharat; Parag Parikh; Camille Noel; Michael Meltsner; Karl Bzdusek; Michael Kaus
Journal:  Med Phys       Date:  2012-01       Impact factor: 4.071

Review 2.  Motion management in gastrointestinal cancers.

Authors:  Hassan Abbas; Bryan Chang; Zhe Jay Chen
Journal:  J Gastrointest Oncol       Date:  2014-06

3.  Biological impact of geometric uncertainties: what margin is needed for intra-hepatic tumors?

Authors:  Hsiang-Chi Kuo; Wen-Shan Liu; Andrew Wu; Dennis Mah; Keh-Shih Chuang; Linda Hong; Ravi Yaparpalvi; Chandan Guha; Shalom Kalnicki
Journal:  Radiat Oncol       Date:  2010-06-03       Impact factor: 3.481

4.  3D dosimetric validation of ultrasound-guided radiotherapy with a dynamically deformable abdominal phantom.

Authors:  Charles K Matrosic; Wesley Culberson; Andrew Shepard; Sydney Jupitz; Bryan Bednarz
Journal:  Phys Med       Date:  2021-04-23       Impact factor: 2.685

5.  Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.

Authors:  Judit Boda-Heggemann; Dietmar Dinter; Christel Weiss; Anian Frauenfeld; Kerstin Siebenlist; Ulrike Attenberger; Martine Ottstadt; Frank Schneider; Ralf-Dieter Hofheinz; Frederik Wenz; Frank Lohr
Journal:  Radiat Oncol       Date:  2012-06-18       Impact factor: 3.481

6.  Magnitude and influencing factors of respiration-induced liver motion during abdominal compression in patients with intrahepatic tumors.

Authors:  Yong Hu; Yong-Kang Zhou; Yi-Xing Chen; Zhao-Chong Zeng
Journal:  Radiat Oncol       Date:  2017-01-10       Impact factor: 3.481

Review 7.  Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy.

Authors:  Jimm Grimm; Tamara LaCouture; Raymond Croce; Inhwan Yeo; Yunping Zhu; Jinyu Xue
Journal:  J Appl Clin Med Phys       Date:  2011-02-08       Impact factor: 2.243

8.  Dosimetric and clinical effects of interfraction and intrafraction correlation errors during marker-based real-time tumor tracking for liver SBRT.

Authors:  Keita Kurosu; Iori Sumida; Osamu Suzuki; Hiroya Shiomi; Seiichi Ota; Keisuke Otani; Keisuke Tamari; Yuji Seo; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.